EP Patent

EP2314700A1 — Composition and method for in vivo and in vitro attenuation of gene expression using double stranded RNA

Assigned to Augusta University Research Institute Inc · Expires 2011-04-27 · 15y expired

What this patent protects

Introduction of double stranded RNA into cells, cell culture, organs and tissues, and whole organisms, particularly vertebrates, specifically attenuates gene expression.

USPTO Abstract

Introduction of double stranded RNA into cells, cell culture, organs and tissues, and whole organisms, particularly vertebrates, specifically attenuates gene expression.

Drugs covered by this patent

Patent Metadata

Patent number
EP2314700A1
Jurisdiction
EP
Classification
—
Expires
2011-04-27
Drug substance claim
No
Drug product claim
No
Assignee
Augusta University Research Institute Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.